严重钝性创伤与失血性休克后不同免疫内型与临床轨迹相关
本研究为前瞻性纵向队列的二次分析,纳入2个一级创伤中心102例严重钝性创伤合并失血性休克患者,在伤后0.5、1、4、7、14、28天检测循环免疫生物标志物,用K-means聚类依据总体均值和轨迹斜率识别免疫内型。共识别出iA、iB、iC三种内型:iA以快速恢复为主(93.6%),iB以慢性危重症(CCI)发生率最高(22.7%),iC也以快速恢复为主(81.8%)。iB型器官功能障碍最重、持续时间最长,院内感染发生率50%(p=0.001),且CCI患者中76.9%为iB型(p=0.002)。提示持续炎症/免疫抑制内型与不良临床结局相关,可能有助于早期风险分层。
要点
- 在102例严重钝性创伤失血性休克患者中识别出iA、iB、iC三种免疫内型,各自与不同临床轨迹相关。
- iB型(n=44)表现为早期高炎症反应伴持续炎症和免疫抑制,CCI发生率最高(22.7%)。
- iB型患者器官功能障碍严重程度和持续时间最高,院内感染发生率50%(p=0.001)。
- 13例CCI患者中10例(76.9%)为iB型(p=0.002),iB是CCI的主要内型。
- iA型(n=47)和iC型(n=11)以快速恢复为主,分别为93.6%和81.8%。
适用人群与场景
- 严重钝性创伤合并失血性休克患者,来自2个一级创伤中心的前瞻性纵向队列,共102例。
- 原文未提及具体纳入/排除标准及急诊/ICU/院前场景的进一步限定。
诊断标准与关键阈值
- 采用K-means聚类,依据所选免疫生物标志物的总体均值和轨迹斜率识别免疫内型。
- 临床轨迹定义:早期死亡为伤后<14天死亡;慢性危重症(CCI)为ICU住院时间≥14天且持续器官功能障碍;快速恢复(RAP)为ICU住院时间<14天且器官功能恢复。
- 原文未提及具体生物标志物名称及聚类界值。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型为前瞻性纵向队列研究的二次分析,纳入2个一级创伤中心102例严重钝性创伤失血性休克患者。
- 识别出三种免疫内型:iA(n=47)中度初始促炎反应后恢复免疫稳态,RAP占93.6%(n=44);iB(n=44)早期高炎症反应伴持续炎症和免疫抑制,CCI发生率最高(22.7%,n=10);iC(n=11)类似高炎症反应但快速恢复免疫稳态,RAP占81.8%(n=9)。
- iB型患者器官功能障碍严重程度和持续时间最高,院内感染发生率50%(p=0.001)。
- CCI患者中iB型占76.9%(10/13,p=0.002)。
证据类型、等级与局限
- 证据类型:前瞻性纵向队列研究的二次分析。
- 原文给出的证据等级:预后研究,level III。
- 局限:原文未明确列出;设计上为二次分析、样本量102例、仅2个中心。
对床旁实践的改变
- 原文提示iB型(持续炎症/免疫抑制)与CCI和院内感染高发相关,可能有助于早期识别高风险患者,但原文未给出可直接用于床旁的生物标志物阈值或干预方案。
- 原文未提及基于内型的治疗改变或适用/不适用人群的排除标准。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The genomic/cytokine "storm" after severe trauma is well described. However, the differing composition, magnitude and resolution of this response, and its relationship to clinical outcomes remain unclear.
METHODS: This is a secondary analysis of a prospective longitudinal cohort study of severely injured trauma patients in hemorrhagic shock. Peripheral blood sampling was performed at 0.5, 1, 4, 7, 14, and 28 days after injury for measurement of circulating immune biomarkers. K-means clustering using overall mean and trajectory slope of selected immunologic biomarkers were used to identify distinct temporal immunologic endotypes. Endotypes were compared with known clinical trajectories defined as early death (<14 days), chronic critical illness (CCI) (ICU length of stay of ≥14 days with persistent organ dysfunction), and rapid recovery (RAP) (ICU length of stay of <14 days with organ recovery).
RESULTS: The cohort included 102 subjects enrolled across 2 level 1 trauma centers. We identified three distinct immunologic endotypes (iA, iB, and iC), each with unique associations to clinical trajectory. Endotype iA (n = 47) exhibited a moderate initial proinflammatory response followed by a return to immunologic homeostasis, with a primary clinical trajectory of RAP (n = 44, 93.6%). Endotype iB (n = 44) exhibited an early hyperinflammatory response with persistent inflammation and immunosuppression, with the highest incidence of CCI (n = 10, 22.7%). Endotype iC (n = 11) exhibited a similar hyperinflammatory response, but with rapid return to immunologic homeostasis and a predominant trajectory of RAP (n = 9, 81.8%). Patients with endotype iB had the highest severity/duration of organ dysfunction and highest incidence of nosocomial infections (50%, p = 0.001), and endotype iB was the predominant endotype of patients who developed CCI (10 of 13 patients, 76.9%; p = 0.002).
CONCLUSION: We identified three distinct immunologic endotypes after severe injury differing the magnitude and duration of the early response. The clinical trajectory of CCI is characterized by an endotype (iB) defined by persistent alteration in inflammation/immunosuppression and is associated with poor clinical outcomes.
LEVEL OF EVIDENCE: Prognostic, level III.
参考来源
- Brakenridge SC, Wang Z, Cox M, et al. Distinct immunologic endotypes are associated with clinical trajectory after severe blunt trauma and hemorrhagic shock. J Trauma Acute Care Surg. 2021. PMID: 33214489. doi:10.1097/TA.0000000000003029
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。